Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | CA2 | P00918 | 4/20 | 0.52 |
| ▸ | CA12 | O43570 | 3/20 | 0.52 |
| ▸ | CA9 | Q16790 | 3/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.52 |
| ▸ | CA5A | P35218 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.52 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.48 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA6 | P23280 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | ACHE | P22303 | 2/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30468853 | 0.93 | ESR1 (0.47) | ALDH1A1CA2CA12CA9CYP3A4 | |
| SCHEMBL14993533 | 0.93 | ESR1 (0.47) | ALDH1A1CA2CA12CA9CYP3A4 | |
| SCHEMBL14993693 | 0.91 | ESR1 (0.45) | ALDH1A1CA2CA12CA9CYP3A4 | |
| SCHEMBL4954253 | 0.83 | CA2 (0.54) | ALDH1A1CA2CA12CA9CYP3A4 | |
| SCHEMBL13943762 | 0.81 | ESR1 (0.48) | ALDH1A1CA2CA12CA9CYP3A4 | |
| SCHEMBL3036564 | 0.79 | ESR1 (0.47) | ALDH1A1CA2CA12CA9CYP3A4 | |
| SCHEMBL20090214 | 0.78 | HSD17B1 (0.63) | CYP3A4HSD17B1HSD17B2CYP2C9KMT2A | |
| Resorcinol SCHEMBL130699 | 0.76 | ALDH1A1 (0.71) | ALDH1A1CA2CA12CA9CYP3A4 | |
| Resorcinol SCHEMBL133535 | 0.76 | ALDH1A1 (0.71) | ALDH1A1CA2CA12CA9CYP3A4 | |
| Resorcinol SCHEMBL7768980 | 0.75 | CA2 (0.52) | ALDH1A1CA2CA12CA9CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11866560-B2 | Microfluidic flow process for making monomers | UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2024-01-09 | — | — | US | claimed |
| US-20220220268-A1 | MICROFLUIDIC FLOW PROCESS FOR MAKING MONOMERS | GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE | 2022-07-14 | — | — | US | claimed |
| US-11319421-B1 | Microfluidic flow process for making monomers | UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2022-05-03 | — | — | US | claimed |
| US-11866560-B2 | Microfluidic flow process for making monomers | UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2024-01-09 | — | — | US | disclosed |
| US-20220220268-A1 | MICROFLUIDIC FLOW PROCESS FOR MAKING MONOMERS | GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE | 2022-07-14 | — | — | US | disclosed |
| US-11326015-B1 | Cyanate ester resin | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2022-05-10 | — | — | US | disclosed |
| US-11319421-B1 | Microfluidic flow process for making monomers | UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2022-05-03 | — | — | US | disclosed |
| US-6969756-B2 | Phosphorus element-containing crosslinking agents and flame retardant phosphorus element-containing epoxy resin compositions prepared therewith | DOW GLOBAL TECHNOLOGIES INC. (US) | 2005-11-29 | — | — | US | disclosed |
| US-20040171769-A1 | Phosphorus element -containing crosslinking agents and flame retardant phosphorus element-containing epoxy resin compositions prepared therewith | BLUE CUBE IP LLC | 2004-09-02 | — | — | US | disclosed |
| US-6740732-B2 | LAMINATES FOR PRINTED WIRING BOARDS | DOW GLOBAL TECHNOLOGIES INC. | 2004-05-25 | — | — | US | disclosed |
| US-6403220-B1 | TRIARYL PHOSPHINE OXIDE CROSSLINKING AGENT; HALOGEN-FREE; IGNITION RESISTANT; LAMINATES FOR PRINTED WIRING BOARDS | THE DOW CHEMICAL COMPANY | 2002-06-11 | — | — | US | disclosed |
| WO-2001042253-A2 | PHOSPHORUS ELEMENT-CONTAINING CROSSLINKING AGENTS AND FLAME RETARDANT PHOSPHORUS ELEMENT-CONTAINING EPOXY RESIN COMPOSITIONS PREPARED THEREWITH | THE DOW CHEMICAL COMPANY (US) | 2001-06-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11326015-B1 | Cyanate ester resin | TH, TYR, LPO | ALDH1A1 1527/4885CA2 1697/4885CA12 1167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.